Company intelligence / Profile preview

Core Access Surgical Technologies

Atlanta, Georgia, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

LevaLap® 1.0, a patented single-use device for laparoscopic access, has completed a post-market clinical follow-up study across eight centers in six countries. Data demonstrates advancements in speed, stability, and precision for safe, efficient abdominal entry in minimally invasive surgery. Clinical results have undergone peer review and will be presented at AAGL Global Congress in 2024[2][5].

Therapeutic areas: Women's HealthOther
Modalities: DeviceSingle-use device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Core Access Surgical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Core Access Surgical Technologies.

Explore the full profile